National Institute of Allergy & Infectious Diseases: Existing Drug Shows Promise as Treatment for Rare Genetic Disorder
May 31, 2024
May 31, 2024
WASHINGTON, May 31 (TNSres) -- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases issued the following news release:
* * *
NIH Researchers Find New Pathways Towards Treatment for Autoimmune Polyendocrine Syndrome Type 1
* * *
A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndro . . .
* * *
NIH Researchers Find New Pathways Towards Treatment for Autoimmune Polyendocrine Syndrome Type 1
* * *
A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndro . . .